Comparative immunogenicity of HIV-1 clade C envelope proteins for prime/boost studies.
<h4>Background</h4>Previous clinical efficacy trials failed to support the continued development of recombinant gp120 (rgp120) as a candidate HIV vaccine. However, the recent RV144 HIV vaccine trial in Thailand showed that a prime/boost immunization strategy involving priming with canary...
Saved in:
| Main Authors: | Douglas H Smith, Peggy Winters-Digiacinto, Misrach Mitiku, Sara O'Rourke, Faruk Sinangil, Terri Wrin, David C Montefiori, Phillip W Berman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-08-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012076&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope
by: Andrew Wilcox-King, et al.
Published: (2025-08-01) -
Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost
by: Ying Liu, et al.
Published: (2025-07-01) -
Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis
by: Masaji Okada, et al.
Published: (2011-01-01) -
Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
by: Antonia Radaelli, et al.
Published: (2024-11-01) -
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
by: Emma T Crooks, et al.
Published: (2021-10-01)